Elevated serum ferritin levels in patients with hematologic malignancies.

Area of Science:

• Hematology
• Clinical Chemistry

Background:

• Serum ferritin is an iron storage protein.
• Elevated serum ferritin levels are observed in various conditions, including inflammation and malignancy.

Purpose of the Study:

• To investigate the variability and clinical significance of serum ferritin levels in Chinese patients diagnosed with hematologic malignancies.
• To determine if serum ferritin levels correlate with disease status (newly diagnosed, recurrent, or remission) and specific hematologic malignancy types.

Main Methods:

• Retrospective analysis of serum ferritin levels in 473 Chinese patients with hematologic malignancies.
• Serum ferritin was measured using radioimmunoassay.
• Patients included those with acute leukemia, lymphoma, and multiple myeloma.

Main Results:

• Serum ferritin levels were significantly higher in patients with newly diagnosed or recurrent hematologic malignancies compared to those in complete remission or healthy controls (p<0.001).
• The study included 262 acute leukemia, 131 lymphoma, and 80 multiple myeloma cases.

Conclusions:

• Increased serum ferritin levels are indicative of active or early-stage hematologic malignancies.
• Monitoring serum ferritin can be a valuable tool for assessing disease status and predicting prognosis in patients with hematologic malignancies.